Hear from CEO Steve Fife, VP of R&D and Regulatory, Lisa Barnes, and Chief Sales Officer, Kristen Cunningham as they cover LV's strategy, marketing position, and long-term growth potential
Semaglutide is a GLP-1 receptor agonist that works by mimicking natural hormones that affect appetite and satiety
From a strict drug-drug interaction standpoint, using these medications simultaneously carries low risk of dangerous chemical reactions
However, the potential gastrointestinal side effects, including the risk of acid reflux due to delayed gastric emptying, present a challenge in its clinical use
Pharmacists Perspective Faryal Faisal, PharmD Resistance training is the single most underused intervention for patients on weight loss medications
Similarly, exenatide-4 inhibits hepatocarcinogenesis independent of obesity and MASH resolution, acting through the cAMP-PKA-EGFR-STAT3 axis and mTOR modulation to suppress proliferation and reduce HCC multiplicity (Zhou et al., 2017)